Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 391

1.

Interplay of Plasmodium falciparum and thrombin in brain endothelial barrier disruption.

Avril M, Benjamin M, Dols MM, Smith JD.

Sci Rep. 2019 Sep 11;9(1):13142. doi: 10.1038/s41598-019-49530-1.

2.

Binding Heterogeneity of Plasmodium falciparum to Engineered 3D Brain Microvessels Is Mediated by EPCR and ICAM-1.

Bernabeu M, Gunnarsson C, Vishnyakova M, Howard CC, Nagao RJ, Avril M, Taylor TE, Seydel KB, Zheng Y, Smith JD.

MBio. 2019 May 28;10(3). pii: e00420-19. doi: 10.1128/mBio.00420-19.

3.

NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment.

Frazao A, Rethacker L, Messaoudene M, Avril MF, Toubert A, Dulphy N, Caignard A.

Front Immunol. 2019 Mar 29;10:661. doi: 10.3389/fimmu.2019.00661. eCollection 2019. Review.

4.

MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort.

Pellegrini C, Botta F, Massi D, Martorelli C, Facchetti F, Gandini S, Maisonneuve P, Avril MF, Demenais F, Bressac-de Paillerets B, Hoiom V, Cust AE, Anton-Culver H, Gruber SB, Gallagher RP, Marrett L, Zanetti R, Dwyer T, Thomas NE, Begg CB, Berwick M, Puig S, Potrony M, Nagore E, Ghiorzo P, Menin C, Manganoni AM, Rodolfo M, Brugnara S, Passoni E, Sekulovic LK, Baldini F, Guida G, Stratigos A, Ozdemir F, Ayala F, Fernandez-de-Misa R, Quaglino P, Ribas G, Romanini A, Migliano E, Stanganelli I, Kanetsky PA, Pizzichetta MA, García-Borrón JC, Nan H, Landi MT, Little J, Newton-Bishop J, Sera F, Fargnoli MC, Raimondi S; IMI Study Group; GEM Study Group; M-SKIP Study Group.

Lancet Child Adolesc Health. 2019 May;3(5):332-342. doi: 10.1016/S2352-4642(19)30005-7. Epub 2019 Mar 12.

PMID:
30872112
5.

Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT.

Taylor NJ, Mitra N, Qian L, Avril MF, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cuellar F, Cust AE, Demenais F, Elder DE, Gerdes AM, Ghiorzo P, Goldstein AM, Grazziotin TC, Gruis NA, Hansson J, Harland M, Hayward NK, Hocevar M, Höiom V, Holland EA, Ingvar C, Landi MT, Landman G, Larre-Borges A, Mann GJ, Nagore E, Olsson H, Palmer JM, Perić B, Pjanova D, Pritchard AL, Puig S, Schmid H, van der Stoep N, Tucker MA, Wadt KAW, Yang XR, Newton-Bishop JA, Kanetsky PA; GenoMEL Study Group.

J Am Acad Dermatol. 2019 Aug;81(2):386-394. doi: 10.1016/j.jaad.2019.01.079. Epub 2019 Feb 5.

PMID:
30731170
6.

Pembrolizumab for Unresectable or Metastatic Melanoma in Patients Older than 85 Years of Age.

Chanal J, Kramkimel N, Ratour C, Aractingi S, Guégan S, Avril MF.

Dermatology. 2019;235(3):219-224. doi: 10.1159/000492467. Epub 2019 Feb 5.

PMID:
30721908
7.

Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma.

Mignard C, Deschamps Huvier A, Gillibert A, Duval Modeste AB, Dutriaux C, Khammari A, Avril MF, Kramkimel N, Mortier L, Marcant P, Lesimple T, Gaudy-Marqueste C, Lesage C, Machet L, Aubin F, Meyer N, Beneton N, Jeudy G, Montaudié H, Arnault JP, Visseaux L, Trabelsi S, Amini-Adle M, Maubec E, Le Corre Y, Lipsker D, Wierzbicka-Hainaut E, Litrowski N, Stefan A, Brunet-Possenti F, Leccia MT, Joly P.

J Oncol. 2018 Dec 2;2018:1908065. doi: 10.1155/2018/1908065. eCollection 2018.

8.

Antibody Targets on the Surface of Plasmodium falciparum-Infected Erythrocytes That Are Associated With Immunity to Severe Malaria in Young Children.

Chan JA, Boyle MJ, Moore KA, Reiling L, Lin Z, Hasang W, Avril M, Manning L, Mueller I, Laman M, Davis T, Smith JD, Rogerson SJ, Simpson JA, Fowkes FJI, Beeson JG.

J Infect Dis. 2019 Feb 15;219(5):819-828. doi: 10.1093/infdis/jiy580.

PMID:
30365004
9.

Emerging Role of IL-4-Induced Gene 1 as a Prognostic Biomarker Affecting the Local T-Cell Response in Human Cutaneous Melanoma.

Ramspott JP, Bekkat F, Bod L, Favier M, Terris B, Salomon A, Djerroudi L, Zaenker KS, Richard Y, Molinier-Frenkel V, Castellano F, Avril MF, Prévost-Blondel A.

J Invest Dermatol. 2018 Dec;138(12):2625-2634. doi: 10.1016/j.jid.2018.06.178. Epub 2018 Jul 23.

PMID:
30048651
10.

A fifth subtype of Kaposi's sarcoma, classic Kaposi's sarcoma in men who have sex with men: a cohort study in Paris.

Denis D, Seta V, Regnier-Rosencher E, Kramkimel N, Chanal J, Avril MF, Dupin N.

J Eur Acad Dermatol Venereol. 2018 Aug;32(8):1377-1384. doi: 10.1111/jdv.14831. Epub 2018 Feb 14.

PMID:
29377280
11.

Anaplastic Kaposi's sarcoma: 5 cases of a rare and aggressive type of Kaposi's sarcoma.

Chapalain M, Goldman-Lévy G, Kramkimel N, Carlotti A, Franck N, Lheure C, Audard V, Avril MF, Marcelin AG, Damotte D, Terris B, Aractingi S, Dupin N.

Ann Dermatol Venereol. 2018 Jan;145(1):21-28. doi: 10.1016/j.annder.2017.09.593. Epub 2017 Dec 28.

PMID:
29290414
12.

[Dermatologic surgery, hemophilia and Von Willebrand disease].

Say M, Dupin N, Stieltjes N, Avril MF, Aractingi S, Chanal J.

Ann Dermatol Venereol. 2018 Apr;145(4):233-239. doi: 10.1016/j.annder.2017.10.009. Epub 2017 Nov 14. French.

PMID:
29150153
13.

Declining Malaria Transmission Differentially Impacts the Maintenance of Humoral Immunity to Plasmodium falciparum in Children.

Mugyenyi CK, Elliott SR, Yap XZ, Feng G, Boeuf P, Fegan G, Osier FFH, Fowkes FJI, Avril M, Williams TN, Marsh K, Beeson JG.

J Infect Dis. 2017 Oct 17;216(7):887-898. doi: 10.1093/infdis/jix370.

14.

Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas.

Bal E, Park HS, Belaid-Choucair Z, Kayserili H, Naville M, Madrange M, Chiticariu E, Hadj-Rabia S, Cagnard N, Kuonen F, Bachmann D, Huber M, Le Gall C, Côté F, Hanein S, Rosti RÖ, Aslanger AD, Waisfisz Q, Bodemer C, Hermine O, Morice-Picard F, Labeille B, Caux F, Mazereeuw-Hautier J, Philip N, Levy N, Taieb A, Avril MF, Headon DJ, Gyapay G, Magnaldo T, Fraitag S, Crollius HR, Vabres P, Hohl D, Munnich A, Smahi A.

Nat Med. 2017 Oct;23(10):1226-1233. doi: 10.1038/nm.4368. Epub 2017 Sep 4.

15.

STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network.

Delyon J, Chevret S, Jouary T, Dalac S, Dalle S, Guillot B, Arnault JP, Avril MF, Bedane C, Bens G, Pham-Ledard A, Mansard S, Grange F, Machet L, Meyer N, Legoupil D, Saiag P, Idir Z, Renault V, Deleuze JF, Hindie E, Battistella M, Dumaz N, Mourah S, Lebbe C; GCC (French Group of Skin Cancer).

J Invest Dermatol. 2018 Jan;138(1):58-67. doi: 10.1016/j.jid.2017.07.839. Epub 2017 Aug 24.

16.

Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families.

Taylor NJ, Mitra N, Goldstein AM, Tucker MA, Avril MF, Azizi E, Bergman W, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cannon-Albright LA, Cuellar F, Cust AE, Demenais F, Elder DE, Gerdes AM, Ghiorzo P, Grazziotin TC, Hansson J, Harland M, Hayward NK, Hocevar M, Höiom V, Ingvar C, Landi MT, Landman G, Larre-Borges A, Leachman SA, Mann GJ, Nagore E, Olsson H, Palmer JM, Perić B, Pjanova D, Pritchard A, Puig S, van der Stoep N, Wadt KAW, Whitaker L, Yang XR, Newton Bishop JA, Gruis NA, Kanetsky PA; GenoMEL Study Group.

J Invest Dermatol. 2017 Dec;137(12):2606-2612. doi: 10.1016/j.jid.2017.07.829. Epub 2017 Aug 19.

17.

Erratum to: Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients.

Heidelberger V, Goldwasser F, Kramkimel N, Jouinot A, Huillard O, Boudou-Rouquette P, Chanal J, Arrondeau J, Franck N, Alexandre J, Blanchet B, Leroy K, Avril MF, Dupin N, Aractingi S.

Invest New Drugs. 2017 Aug;35(4):537. doi: 10.1007/s10637-017-0475-7. No abstract available.

PMID:
28597150
18.

Germline CDKN2A/P16INK4A mutations contribute to genetic determinism of sarcoma.

Jouenne F, Chauvot de Beauchene I, Bollaert E, Avril MF, Caron O, Ingster O, Lecesne A, Benusiglio P, Terrier P, Caumette V, Pissaloux D, de la Fouchardière A, Cabaret O, N'Diaye B, Velghe A, Bougeard G, Mann GJ, Koscielny S, Barrett JH, Harland M, Newton-Bishop J, Gruis N, Van Doorn R, Gauthier-Villars M, Pierron G, Stoppa-Lyonnet D, Coupier I, Guimbaud R, Delnatte C, Scoazec JY, Eggermont AM, Feunteun J, Tchertanov L, Demoulin JB, Frebourg T, Bressac-de Paillerets B.

J Med Genet. 2017 Sep;54(9):607-612. doi: 10.1136/jmedgenet-2016-104402. Epub 2017 Jun 7.

19.

Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib.

Frazao A, Colombo M, Fourmentraux-Neves E, Messaoudene M, Rusakiewicz S, Zitvogel L, Vivier E, Vély F, Faure F, Dréno B, Benlalam H, Bouquet F, Savina A, Pasmant E, Toubert A, Avril MF, Caignard A.

Cancer Immunol Res. 2017 Jul;5(7):582-593. doi: 10.1158/2326-6066.CIR-16-0380. Epub 2017 Jun 2.

20.

Clinical parameters associated with anti-programmed death-1 (PD-1) inhibitors-induced tumor response in melanoma patients.

Heidelberger V, Goldwasser F, Kramkimel N, Jouinot A, Franck N, Arrondeau J, Guégan S, Mansuet-Lupo A, Alexandre J, Damotte D, Avril MF, Dupin N, Aractingi S.

Invest New Drugs. 2017 Dec;35(6):842-847. doi: 10.1007/s10637-017-0476-6. Epub 2017 May 31.

PMID:
28569347
21.

Gaze Behavior Consistency among Older and Younger Adults When Looking at Emotional Faces.

Chaby L, Hupont I, Avril M, Luherne-du Boullay V, Chetouani M.

Front Psychol. 2017 Apr 13;8:548. doi: 10.3389/fpsyg.2017.00548. eCollection 2017.

22.

IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma.

Bod L, Lengagne R, Wrobel L, Ramspott JP, Kato M, Avril MF, Castellano F, Molinier-Frenkel V, Prévost-Blondel A.

Oncoimmunology. 2017 Jan 13;6(3):e1278331. doi: 10.1080/2162402X.2016.1278331. eCollection 2017.

23.

Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients.

Heidelberger V, Goldwasser F, Kramkimel N, Jouinot A, Huillard O, Boudou-Rouquette P, Chanal J, Arrondeau J, Franck N, Alexandre J, Blanchet B, Leroy K, Avril MF, Dupin N, Aractingi S.

Invest New Drugs. 2017 Aug;35(4):436-441. doi: 10.1007/s10637-017-0464-x. Epub 2017 Apr 10. Erratum in: Invest New Drugs. 2017 Jun 9;:.

PMID:
28396974
24.

Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.

Bonet C, Luciani F, Ottavi JF, Leclerc J, Jouenne FM, Boncompagni M, Bille K, Hofman V, Bossis G, Marco de Donatis G, Strub T, Cheli Y, Ohanna M, Luciano F, Marchetti S, Rocchi S, Birling MC, Avril MF, Poulalhon N, Luc T, Hofman P, Lacour JP, Davidson I, Bressac-de Paillerets B, Ballotti R, Marine JC, Bertolotto C.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw340.

PMID:
28376192
25.

Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers.

Muller M, Ferlicot S, Guillaud-Bataille M, Le Teuff G, Genestie C, Deveaux S, Slama A, Poulalhon N, Escudier B, Albiges L, Soufir N, Avril MF, Gardie B, Saldana C, Allory Y, Gimenez-Roqueplo AP, Bressac-de Paillerets B, Richard S, Benusiglio PR.

Clin Genet. 2017 Dec;92(6):606-615. doi: 10.1111/cge.13014. Epub 2017 May 2. Erratum in: Clin Genet. 2018 May;93(5):1118.

PMID:
28300276
26.

[Dermatoses and herpes superinfection: A retrospective study of 34 cases].

Seta V, Fichel F, Méritet JF, Bouam S, Franck N, Avril MF, Dupin N.

Ann Dermatol Venereol. 2017 Mar;144(3):176-181. doi: 10.1016/j.annder.2017.01.011. Epub 2017 Feb 24. French.

PMID:
28242091
27.

Ugly Duckling Sign as a Major Factor of Efficiency in Melanoma Detection.

Gaudy-Marqueste C, Wazaefi Y, Bruneu Y, Triller R, Thomas L, Pellacani G, Malvehy J, Avril MF, Monestier S, Richard MA, Fertil B, Grob JJ.

JAMA Dermatol. 2017 Apr 1;153(4):279-284. doi: 10.1001/jamadermatol.2016.5500.

PMID:
28196213
28.

BRAF V600 inhibitor discontinuation after complete response in advanced melanoma: a retrospective analysis of 16 patients.

Vanhaecke C, Deilhes F, Chanal J, Regnier-Rosencher E, Boitier F, Boulinguez S, Avril MF, Guégan S, Dupin N, Aractingi S, Meyer N, Kramkimel N.

Br J Dermatol. 2017 Oct;177(4):e94-e95. doi: 10.1111/bjd.15345. Epub 2017 Aug 30. No abstract available.

PMID:
28129668
29.

NKp30 isoforms and NKp46 transcripts in metastatic melanoma patients: Unique NKp30 pattern in rare melanoma patients with favorable evolution.

Messaoudene M, Fregni G, Enot D, Jacquelot N, Neves E, Germaud N, Garchon HJ, Boukouaci W, Tamouza R, Chanal J, Avril MF, Toubert A, Zitvogel L, Rusakiewicz S, Caignard A.

Oncoimmunology. 2016 Mar 10;5(12):e1154251. doi: 10.1080/2162402X.2016.1154251. eCollection 2016.

30.

Pathogenicity Determinants of the Human Malaria Parasite Plasmodium falciparum Have Ancient Origins.

Brazier AJ, Avril M, Bernabeu M, Benjamin M, Smith JD.

mSphere. 2017 Jan 11;2(1). pii: e00348-16. doi: 10.1128/mSphere.00348-16. eCollection 2017 Jan-Feb.

31.

Neutrophilic eccrine hidradenitis in two patients treated with BRAF inhibitors: a new cutaneous adverse event.

Herms F, Franck N, Kramkimel N, Fichel F, Delaval L, Laurent-Roussel S, Carlotti A, Avril MF.

Br J Dermatol. 2017 Jun;176(6):1645-1648. doi: 10.1111/bjd.15259. Epub 2017 Apr 16.

PMID:
28005274
32.

Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study.

McArthur GA, Maio M, Arance A, Nathan P, Blank C, Avril MF, Garbe C, Hauschild A, Schadendorf D, Hamid O, Fluck M, Thebeau M, Schachter J, Kefford R, Chamberlain M, Makrutzki M, Robson S, Gonzalez R, Margolin K.

Ann Oncol. 2017 Mar 1;28(3):634-641. doi: 10.1093/annonc/mdw641.

PMID:
27993793
33.

Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs.

Schadendorf D, Lebbé C, Zur Hausen A, Avril MF, Hariharan S, Bharmal M, Becker JC.

Eur J Cancer. 2017 Jan;71:53-69. doi: 10.1016/j.ejca.2016.10.022. Epub 2016 Dec 14. Review.

34.

[Progress and challenges in the management of atypical melanocytic lesions].

Avril MF.

Ann Pathol. 2016 Oct;36(5):303-304. doi: 10.1016/j.annpat.2016.09.001. French. No abstract available.

PMID:
27751404
35.

Thrombin Cleavage of Plasmodium falciparum Erythrocyte Membrane Protein 1 Inhibits Cytoadherence.

Gillrie MR, Renaux B, Russell-Goldman E, Avril M, Brazier AJ, Mihara K, Di Cera E, Milner DA Jr, Hollenberg MD, Smith JD, Ho M.

MBio. 2016 Sep 13;7(5). pii: e01120-16. doi: 10.1128/mBio.01120-16.

36.

Nitric oxide synthase 2 is involved in the pro-tumorigenic potential of γδ17 T cells in melanoma.

Douguet L, Bod L, Lengagne R, Labarthe L, Kato M, Avril MF, Prévost-Blondel A.

Oncoimmunology. 2016 Aug 10;5(8):e1208878. doi: 10.1080/2162402X.2016.1208878. eCollection 2016 Aug.

37.

Melanoma Expression Genes Identified through Genome-Wide Association Study of Breslow Tumor Thickness.

Fang S, Vaysse A, Brossard M, Wang Y, Deng D, Liu Q, Zhang P, Xu K, Li M, Feng R, Liu H, Dang Y, Chen W, Prieto V, Gershenwald JE, Ross MI, Matejka B, Malke J, Haydu LE, Reveille JD, Sui D, Bassett RL Jr, Koshkina N, Avril MF, Lu M, Wei Q, Demenais F, Amos CI, Lee JE.

J Invest Dermatol. 2017 Jan;137(1):253-257. doi: 10.1016/j.jid.2016.07.032. Epub 2016 Aug 6. No abstract available.

38.

Periostitis in secondary syphilis with prozone phenomenon.

Mahévas T, Chanal J, Franck N, Laurent S, Avril MF, Dupin N.

Rheumatology (Oxford). 2016 Nov;55(11):1931. Epub 2016 Aug 7. No abstract available.

PMID:
27498354
39.

Proliferative Nodules vs Melanoma Arising in Giant Congenital Melanocytic Nevi During Childhood.

Vergier B, Laharanne E, Prochazkova-Carlotti M, de la Fouchardière A, Merlio JP, Kadlub N, Avril MF, Bodemer C, Lacoste C, Boralevi F, Taieb A, Ezzedine K, Fraitag S.

JAMA Dermatol. 2016 Oct 1;152(10):1147-1151. doi: 10.1001/jamadermatol.2016.2667.

PMID:
27486690
40.
41.

A comprehensive genome-wide analysis of melanoma Breslow thickness identifies interaction between CDC42 and SCIN genetic variants.

Vaysse A, Fang S, Brossard M, Wei Q, Chen WV, Mohamdi H, Vincent-Fetita L, Margaritte-Jeannin P, Lavielle N, Maubec E, Lathrop M, Avril MF, Amos CI, Lee JE, Demenais F.

Int J Cancer. 2016 Nov 1;139(9):2012-20. doi: 10.1002/ijc.30245. Epub 2016 Jul 23.

42.

Age and clear eyes are associated with an increased risk of cutaneous squamous cell carcinomas in vemurafenib-treated melanoma patients.

Herms F, Kramkimel N, Regnier-Rosencher E, Carlotti A, Chanal J, Boitier F, Aractingi S, Dupin N, Avril MF.

Melanoma Res. 2016 Oct;26(5):487-91. doi: 10.1097/CMR.0000000000000275.

PMID:
27261949
43.

Interaction and behaviour imaging: a novel method to measure mother-infant interaction using video 3D reconstruction.

Leclère C, Avril M, Viaux-Savelon S, Bodeau N, Achard C, Missonnier S, Keren M, Feldman R, Chetouani M, Cohen D.

Transl Psychiatry. 2016 May 24;6:e816. doi: 10.1038/tp.2016.82.

44.

Severe adult malaria is associated with specific PfEMP1 adhesion types and high parasite biomass.

Bernabeu M, Danziger SA, Avril M, Vaz M, Babar PH, Brazier AJ, Herricks T, Maki JN, Pereira L, Mascarenhas A, Gomes E, Chery L, Aitchison JD, Rathod PK, Smith JD.

Proc Natl Acad Sci U S A. 2016 Jun 7;113(23):E3270-9. doi: 10.1073/pnas.1524294113. Epub 2016 May 16.

45.

Complete Penetrance and Absence of Intrafamilial Variability in a Large Family with Hereditary Leiomyomatosis and Renal Cell Carcinoma.

Guinard E, Legendre L, Kramkimel N, Avril MF, Chassaing N, Cabaret O, Guillaud-Bataille M, Mazereeuw Hautier J.

Dermatology. 2016;232(3):293-7. doi: 10.1159/000445430. Epub 2016 May 5.

46.

First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma.

Le Tourneau C, Dreno B, Kirova Y, Grob JJ, Jouary T, Dutriaux C, Thomas L, Lebbé C, Mortier L, Saiag P, Avril MF, Maubec E, Joly P, Bey P, Cosset JM, Sun JS, Asselain B, Devun F, Marty ME, Dutreix M.

Br J Cancer. 2016 May 24;114(11):1199-205. doi: 10.1038/bjc.2016.120. Epub 2016 May 3.

47.

Vulvar hidradenoma papilliferum (HP) is located on the sites of mammary-like anogenital glands (MLAGs): Analysis of the photographs of 52 tumors.

El-Khoury J, Renald MH, Plantier F, Avril MF, Moyal-Barracco M.

J Am Acad Dermatol. 2016 Aug;75(2):380-4. doi: 10.1016/j.jaad.2016.01.034. Epub 2016 Mar 2.

PMID:
26944596
48.

Management of Epidermolytic Ichthyosis in the Newborn.

Avril M, Riley C.

Neonatal Netw. 2016;35(1):19-28. doi: 10.1891/0730-0832.35.1.19.

PMID:
26842536
49.

Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families.

Taylor NJ, Handorf EA, Mitra N, Avril MF, Azizi E, Bergman W, Bianchi-Scarrà G, Bishop DT, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Cuellar F, Cust AE, Demenais F, Elder DE, Friedman E, Gerdes AM, Ghiorzo P, Goldstein AM, Grazziotin TC, Hansson J, Hayward NK, Hocevar M, Höiom V, Holland EA, Ingvar C, Landi MT, Landman G, Larre-Borges A, Leachman SA, Mann GJ, Nagore E, Olsson H, Palmer J, Perić B, Pjanova D, Puig S, Schmid H, van der Stoep N, Tucker MA, Wadt KAW, Whitaker L, Yang XR, Newton Bishop JA, Gruis NA, Kanetsky PA; GenoMEL Consortium.

J Invest Dermatol. 2016 May;136(5):1066-1069. doi: 10.1016/j.jid.2016.01.009. Epub 2016 Jan 28. No abstract available.

50.

Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapy.

Servy A, Maubec E, Sugier PE, Grange F, Mansard S, Lesimple T, Marinho E, Couturaud B, Girod A, Albert S, Dendale R, Calitchi E, Sarda L, Chanal J, Deschamps L, Sastre-Garau X, Laroche L, Crickx B, Avril MF.

Ann Oncol. 2016 May;27(5):914-9. doi: 10.1093/annonc/mdw035. Epub 2016 Jan 24.

PMID:
26811346

Supplemental Content

Support Center